Related content

FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines

By Talbot Jean-Noël   Kerrou Khaldoun   Montravers Françoise   Nataf Valérie   Chevalme Yanna  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 7, 2007-07 ,pp. : 1131-1132

Springer Publishing Company

Access to resources Recommend Favorite

Imaging of tumour hypoxia using PET and ¹⁸F-labelled tracers: biology meets technology

By Grönroos Tove   Minn Heikki  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1563-1565

Springer Publishing Company

Access to resources Recommend Favorite

EANM procedure guidelines for ¹³¹I-meta-iodobenzylguanidine (¹³¹I-mIBG) therapy

By Giammarile Francesco   Chiti Arturo   Lassmann Michael   Brans Boudewijn   Flux Glenn  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 5, 2008-05 ,pp. : 1039-1047

Springer Publishing Company

Access to resources Recommend Favorite

In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy

By Capello Astrid   Krenning Eric   Bernard Bert   Reubi Jean-Claude   Breeman Wout   Jong Marion  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, Iss. 11, 2005-11 ,pp. : 1288-1295

Springer Publishing Company

Access to resources Recommend Favorite

EANM-ESR white paper on multimodality imaging

By Carrió Ignasi  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 673-673

Springer Publishing Company

Access to resources Recommend Favorite